Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert F Reynolds

Showing results (1-10 of 39) with videos related to

Pageof 4
Sort By:
Menopause (New York, N.Y.)|January 13, 2004
Predicting time to menopause using self-reported menstrual dataRobert F Reynolds
American Journal of Human Biology : the Official Journal of the Human Biology Council|April 26, 2005
Age at natural menopause in Spain and the United States: results from the DAMES projectRobert F Reynolds, Carla Makhlouf Obermeyer
Current Medical Research and Opinion|May 30, 2008
Integrating evidence from multiple sources to evaluate post-approval safety: an example of sildenafil citrate and cardiovascular eventsRachel E Sobel, Robert F Reynolds
Therapeutic Advances in Drug Safety|January 11, 2018
The hope, hype and reality of Big Data for pharmacovigilanceAndrew Bate, Robert F Reynolds, Patrick Caubel
Drug Safety|October 11, 2018
Real World Evidence: Time for a Switch?Rachel E Sobel, Andrew Bate, Robert F Reynolds
Annals of Botany|July 2, 2009
Simulating carbon dioxide exchange rates of deciduous tree species: evidence for a general pattern in biochemical changes and water stress responseRobert F Reynolds, William L Bauerle, Ying Wang
Clinical Pharmacology and Therapeutics|April 27, 2019
A Structured Preapproval and Postapproval Comparative Study Design Framework to Generate Valid and Transparent Real-World Evidence for Regulatory DecisionsNicolle M Gatto, Robert F Reynolds, Ulka B Campbell
Menopause (New York, N.Y.)|July 10, 2004
Therapeutic decisions for menopause: results of the DAMES project in central MassachusettsCarla Makhlouf Obermeyer, Robert F Reynolds, Kim Price, et al.
Maturitas|November 22, 2002
The role of treatment intentions and concerns about side effects in women's decision to discontinue postmenopausal hormone therapyRobert F Reynolds, Carla Makhlouf Obermeyer, Alexander M Walker, et al.
Therapeutic Advances in Drug Safety|August 21, 2019
Hypothesis-free signal detection in healthcare databases: finding its value for pharmacovigilanceAndrew Bate, Ken Hornbuckle, Juhaeri Juhaeri, et al.
Pageof 4

Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
Menopause (New York, N.Y.)|January 13, 2004
Predicting time to menopause using self-reported menstrual dataRobert F Reynolds
American Journal of Human Biology : the Official Journal of the Human Biology Council|April 26, 2005
Age at natural menopause in Spain and the United States: results from the DAMES projectRobert F Reynolds, Carla Makhlouf Obermeyer
Current Medical Research and Opinion|May 30, 2008
Integrating evidence from multiple sources to evaluate post-approval safety: an example of sildenafil citrate and cardiovascular eventsRachel E Sobel, Robert F Reynolds
Therapeutic Advances in Drug Safety|January 11, 2018
The hope, hype and reality of Big Data for pharmacovigilanceAndrew Bate, Robert F Reynolds, Patrick Caubel
Drug Safety|October 11, 2018
Real World Evidence: Time for a Switch?Rachel E Sobel, Andrew Bate, Robert F Reynolds
Annals of Botany|July 2, 2009
Simulating carbon dioxide exchange rates of deciduous tree species: evidence for a general pattern in biochemical changes and water stress responseRobert F Reynolds, William L Bauerle, Ying Wang
Clinical Pharmacology and Therapeutics|April 27, 2019
A Structured Preapproval and Postapproval Comparative Study Design Framework to Generate Valid and Transparent Real-World Evidence for Regulatory DecisionsNicolle M Gatto, Robert F Reynolds, Ulka B Campbell
Menopause (New York, N.Y.)|July 10, 2004
Therapeutic decisions for menopause: results of the DAMES project in central MassachusettsCarla Makhlouf Obermeyer, Robert F Reynolds, Kim Price, et al.
Maturitas|November 22, 2002
The role of treatment intentions and concerns about side effects in women's decision to discontinue postmenopausal hormone therapyRobert F Reynolds, Carla Makhlouf Obermeyer, Alexander M Walker, et al.
Therapeutic Advances in Drug Safety|August 21, 2019
Hypothesis-free signal detection in healthcare databases: finding its value for pharmacovigilanceAndrew Bate, Ken Hornbuckle, Juhaeri Juhaeri, et al.
Pageof 4